Skip to main content
Transpek Industry Ltd. logo

Transpek Industry Ltd. — Investor Relations & Filings

Ticker · TRANSPEK ISIN · INE687A01016 LEI · 335800RB49U7JFY3VP05 BSE.NS Manufacturing
Open in API
Filings indexed 467 across all filing types
Latest filing 2025-12-05 Regulatory Filings
Country IN India
Listing BSE.NS TRANSPEK

About Transpek Industry Ltd.

https://transpek.com/

Transpek Industry Ltd. is a manufacturer specializing in the synthesis of acid chlorides and sulfur-based chemicals. The company focuses on the production of Thionyl Chloride and its derivatives, serving as a critical supplier for the pharmaceutical, agrochemical, and performance polymer sectors. Its core competencies include complex chemical processes such as chlorination, which facilitates the creation of high-purity intermediates. Transpek maintains a strong emphasis on research and development to optimize process chemistry and scale up specialized molecules. The company provides a diverse portfolio of products, including Isophthaloyl Chloride (IPC) and Terephthaloyl Chloride (TPC), utilized in the manufacturing of high-strength fibers and engineering plastics. With a focus on safety and environmental compliance, it manages large-scale hazardous chemical operations to support global supply chains.

Recent filings

Filing Released Lang Actions
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashwin C Shroff
Regulatory Filings
2025-12-05 English
Intimation of Certification for Great Place to Work
Regulatory Filings Classification · 95% confidence The document is a certification letter stating that Transpek Industry Limited has been certified as a great workplace by Great Place To Work®, India. It is a short document (598 characters) and does not contain any financial data, regulatory announcements, or report content. It is primarily a certification and attestation document, which does not fit into any specific financial report category. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS).
2025-12-03 English
Intimation of certificate received for Great Place To Work.
Regulatory Filings Classification · 100% confidence The document text is extremely short (only 101 characters) and contains only a digital signature with a date and time stamp. There is no substantive content, financial data, or report information. It does not contain any report, announcement, or detailed information. Given the lack of content, this document best fits the fallback category for miscellaneous filings that do not fit other categories, which is Regulatory Filings (RNS).
2025-12-03 English
Investor Presentation November 2025.
Investor Presentation Classification · 98% confidence The document is titled 'Investor Presentation' for Transpek Industry Limited dated November 2025. It contains detailed financial highlights for Q2 and H1 FY26, including revenue, EBITDA, PAT, segment and regional sales breakdowns, consolidated profit & loss account, and balance sheet data. It also includes business strategy, market outlook, awards, and company background information. The content is typical of a presentation prepared for investors focusing on financial performance, strategy, and market position. The document length is about 15,000 characters, indicating a full presentation rather than a brief announcement or a certification. There is no indication that this is an official annual or quarterly report filing, audit report, or earnings release. The presence of forward-looking statements and detailed financial metrics aligns with an investor presentation rather than other filing types. Therefore, the document best fits the category of Investor Presentation (IP).
2025-11-24 English
Cancel the proposal for listing of shares on NSE due to Company being ineligible for listing as per revised criteria
Regulatory Filings Classification · 100% confidence The document text is extremely short (only 100 characters) and contains only a digital signature with no substantive content or financial data. There is no indication of any report, announcement, or detailed information. Given the lack of content, this document does not fit any specific report category and defaults to a Regulatory Filing (RNS) as a fallback for miscellaneous filings.
2025-11-13 English
Unaudited Results for the quarter and half year ended 30.09.2025
Regulatory Filings
2025-11-13 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.